Kyung Dong Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Kyung Dong Pharmaceutical has a total shareholder equity of ₩228.5B and total debt of ₩15.0B, which brings its debt-to-equity ratio to 6.6%. Its total assets and total liabilities are ₩293.0B and ₩64.5B respectively.
Key information
6.6%
Debt to equity ratio
₩15.02b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩32.07b |
| Equity | ₩228.48b |
| Total liabilities | ₩64.49b |
| Total assets | ₩292.97b |
Recent financial health updates
Is Kyung Dong Pharmaceutical (KOSDAQ:011040) A Risky Investment?
Mar 07
We Think Kyung Dong Pharmaceutical (KOSDAQ:011040) Can Manage Its Debt With Ease
Dec 05Recent updates
Is Kyung Dong Pharmaceutical (KOSDAQ:011040) A Risky Investment?
Mar 07Consider This Before Buying Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) For The 1.9% Dividend
Feb 18
Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Share Price Gain of 27% Match Its Business Performance?
Feb 03Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 19Kyung Dong Pharmaceutical Co., Ltd.'s (KOSDAQ:011040) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04How Much Of Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) Do Insiders Own?
Dec 20We Think Kyung Dong Pharmaceutical (KOSDAQ:011040) Can Manage Its Debt With Ease
Dec 05Financial Position Analysis
Short Term Liabilities: A011040's short term assets (₩89.7B) exceed its short term liabilities (₩59.0B).
Long Term Liabilities: A011040's short term assets (₩89.7B) exceed its long term liabilities (₩5.5B).
Debt to Equity History and Analysis
Debt Level: A011040 has more cash than its total debt.
Reducing Debt: A011040's debt to equity ratio has increased from 0.5% to 6.6% over the past 5 years.
Debt Coverage: A011040's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A011040's interest payments on its debt are well covered by EBIT.